Virus-based nanoparticles as platform technologies for modern vaccines

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Jul;8(4):554-78. doi: 10.1002/wnan.1383. Epub 2016 Jan 19.

Abstract

Nanoscale engineering is revolutionizing the development of vaccines and immunotherapies. Viruses have played a key role in this field because they can function as prefabricated nanoscaffolds with unique properties that are easy to modify. Viruses are immunogenic via multiple pathways, and antigens displayed naturally or by engineering on the surface can be used to create vaccines against the cognate virus, other pathogens, specific molecules or cellular targets such as tumors. This review focuses on the development of virus-based nanoparticle systems as vaccines indicated for the prevention or treatment of infectious diseases, chronic diseases, cancer, and addiction. WIREs Nanomed Nanobiotechnol 2016, 8:554-578. doi: 10.1002/wnan.1383 For further resources related to this article, please visit the WIREs website.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Drug Delivery Systems / methods*
  • Humans
  • Mice
  • Nanomedicine / methods*
  • Nanoparticles* / chemistry
  • Nanoparticles* / ultrastructure
  • Vaccination
  • Vaccines*
  • Virion* / chemistry
  • Virion* / ultrastructure

Substances

  • Vaccines